The Florida Senate
BILL ANALYSIS AND FISCAL IMPACT STATEMENT
(This document is based on the provisions contained in the legislation as of the latest date listed below.)
Prepared By: The Professional Staff of the Committee on Judiciary
BILL: CS/SB 514
INTRODUCER: Judiciary Committee and Senator Harrell
SUBJECT: Medical Review Committees
DATE: March 5, 2025
ANALYST STAFF DIRECTOR REFERENCE ACTION
1. Collazo Cibula JU Fav/CS
2. CF
3. RC
Please see Section IX. for Additional Information:
COMMITTEE SUBSTITUTE - Technical Changes
I. Summary:
CS/SB 514 adds managing entities and employees of a managing entity to the list of state
agencies, health care providers, and health care professionals that are authorized to participate in
a medical review committee. A managing entity is a corporation under contract with the
Department of Children and Families to manage the daily operational delivery of behavioral
health services, which include mental health services and substance abuse services.
Participants in medical review committees are generally immune from liability for their actions
in evaluating the quality and costs of previously provided health care services. Likewise,
information relating to the proceedings, including witness testimony before a committee, is not
discoverable or admissible in civil or administrative actions.
Accordingly, by allowing managing entities and their employees to participate in medical review
committees, the bill grants them the same confidentiality protections and liability protections that
apply to other medical review committees authorized by existing law.
The bill takes effect July 1, 2025.
REVISED: BILL: CS/SB 514 Page 2
II. Present Situation:
Medical Review Committees
Generally
A “medical review committee” is a committee of certain health care providers, organizations, or
institutions that is formed to evaluate and improve the quality of health care rendered by
providers of health service. A medical review committee determines whether:
• Health services rendered were professionally indicated or were performed in compliance
with the applicable standard of care; or
• The cost of the health care rendered was considered reasonable by the providers of
professional health services in the area.
1
Any of the following entities may establish a medical review committee:
• A hospital, an ambulatory surgical center, or a health maintenance organization.
• A physician-hospital organization, a provider-sponsored organization, or an integrated
delivery system.
• A state or local professional society of health care providers.
• The medical staff of a licensed hospital or nursing home, provided the medical staff operates
pursuant to written bylaws that have been approved by the governing board of the hospital or
nursing home.
• The Department of Corrections or the Correctional Medical Authority or its employees,
agents, or consultants.
• A professional service corporation or a corporation formed and operated for the practice of
medicine, which has at least 25 health care providers who routinely provide health care
services directly to patients.
• The Department of Children and Families, which includes employees, agents, or consultants
to the department as deemed necessary to provide peer review, utilization review, and
mortality review of treatment services.
• A mental health treatment facility or community mental health center, provided the quality
assurance program operates pursuant to guidelines approved by the governing board of the
agency.
• A substance abuse treatment and education prevention program, provided the quality
assurance program operates pursuant to guidelines approved by the governing board of the
agency.
• A peer review or utilization review committee.
• The Department of Health, a county health department, a healthy start coalition, or a certified
rural health network, when reviewing quality of care, or employees of these entities when
reviewing mortality records.
• A continuous quality improvement committee of a licensed pharmacy.
2
1
Section 766.101(1)(a)1.a.-l., F.S. It also includes a committee of an insurer, self-insurer, or joint underwriting association of
medical malpractice insurance, or other persons conducting review under s. 706.106, F.S. Section 766.101(1)(a)2., F.S.
2
Section 766.101(1)(a)1.a.-l., F.S. BILL: CS/SB 514 Page 3
Immunity from Liability
There is no monetary liability on the part of, and no cause of action for damages arising against,
any of the following for any act or proceeding undertaken or performed within the scope of the
functions of any medical review committee (provided the committee member or health care
provider acts without intentional fraud):
• Any member of a duly appointed medical review committee.
• Any health care provider furnishing any information
3
to such committee.
• Any person, including any person acting as a witness, incident reporter to, or investigator for,
a medical review committee.
4
The medical review committee statute does not confer immunity from liability upon any
professional society, hospital, or health professional while performing services other than as a
member of a medical review committee; or upon any person, including any person acting as a
witness, incident reporter to, or investigator for a medical review committee, for any act or
proceeding undertaken or performed outside the scope of the functions of such committee.
5
Each member of, or health care professional consultant to, any committee, board, group,
commission, or other entity is immune from civil liability for any act, decision, omission, or
statement done or made in performance of his or her duties while serving as a member of, or
consultant to, such entity. To qualify, the entity must be established and operated for purposes of
quality improvement review, evaluation, and planning in a state-licensed health care facility;
6
it
must function primarily to review, evaluate, or make recommendations relating to any of the
following:
• The duration of patient stays in health care facilities.
• The professional services furnished with respect to the medical, dental, psychological,
podiatric, chiropractic, or optometric necessity for such services.
• The purpose of promoting the most efficient use of available health care facilities and
services.
• The adequacy or quality of professional services.
• The competency and qualifications for professional staff privileges.
• The reasonableness or appropriateness of charges made by, or on behalf of, health care
facilities.
• Patient safety, including entering into contracts with patient safety organizations.
7
The entity must also be:
• Established in accordance with state law;
• Established in accordance with the requirements of an applicable accrediting organization
whose standards incorporate regulations that are comparable to those required by this state;
• Established and duly constituted by one or more public or licensed private hospitals or
behavioral health agencies; or
3
Information concerning the prescribing of Schedule II substances is included. See s. 766.101(3)(a), F.S. (referencing s.
893.03(2), F.S., which lists Schedule II substances).
4
Section 766.101(3)(a), F.S.
5
Section 766.101(4), F.S.
6
Section 766.1015(1), F.S.
7
Id. BILL: CS/SB 514 Page 4
• Established by a governmental agency.
8
Moreover, to qualify for the statute’s immunity protections, the act, decision, omission, or
statement may not be made or done in bad faith or with malicious intent.
9
III. Effect of Proposed Changes:
The bill expands the definition of “medical review committee” to permit not only the
establishment of such committees by the Department of Children and Families, as is already
permitted under existing law,
10
but also the establishment of medical review committees by a
“managing entity.”
A “managing entity” is a corporation selected by and under contract with the department to
manage the daily operational delivery of behavioral health services through a coordinated system
of care.
11
The bill also provides that the committee created by the managing entity may include employees
or agents of, or consultants to, the department or the managing entity and any other persons the
department or the managing entity deems necessary to provide peer review, utilization review, or
mortality review of treatment services provided pursuant to state law.
12
By expanding the definition of “medical review committee” in this way, the bill extends the
immunity protections that currently apply to medical review committees to committees
established by managing entities as well.
Likewise, the restrictions on discovery and the admissibility of evidence relating to the other
medical review committees authorized by existing law apply to the medical review committees
authorized by the bill. Under these specific restrictions, the investigations, proceedings, and
records of a medical review committee, arising out of the matters which are the subject of
evaluation and review by such committee, are not subject to discovery or introduction into
evidence in any civil or administrative action against a managing entity.
The bill takes effect July 1, 2025.
IV. Constitutional Issues:
A. Municipality/County Mandates Restrictions:
None.
8
Section 766.1015(2), F.S.
9
Id.
10
Section 766.101(1)(a)1.g., F.S.
11
Section 394.9082(2), F.S.
12
Specifically, chs. 394 (mental health), 397 (substance abuse services), and 916 (mentally ill and intellectually disabled
defendants), F.S. BILL: CS/SB 514 Page 5
B. Public Records/Open Meetings Issues:
None.
C. Trust Funds Restrictions:
None.
D. State Tax or Fee Increases:
None.
E. Other Constitutional Issues:
None.
V. Fiscal Impact Statement:
A. Tax/Fee Issues:
None.
B. Private Sector Impact:
Any managing entity under contract with the Department of Children and Families may
incur increased costs associated with the appointing and funding of a medical review
committee, if the department does not assume those costs directly.
C. Government Sector Impact:
The Department of Children and Families may save costs associated with the appointing
and funding of a medical review committee, if a managing entity under contract with the
department assumes those costs instead.
VI. Technical Deficiencies:
None.
VII. Related Issues:
None.
VIII. Statutes Affected:
This bill substantially amends section 766.101 of the Florida Statutes. BILL: CS/SB 514 Page 6
IX. Additional Information:
A. Committee Substitute – Statement of Changes:
(Summarizing differences between the Committee Substitute and the prior version of the bill.)
CS by Judiciary on March 4, 2025:
The committee substitute corrects a typographical error by deleting the word
“malpractice” from the short title of the bill.
B. Amendments:
None.
This Senate Bill Analysis does not reflect the intent or official position of the bill’s introducer or the Florida Senate.